e-Drug3D

519

FLUTAMIDE


INN
FLUTAMIDE

(has an active metabolite)

cas 13311-84-7
CLASS

ANTINEOPLASTIC
ANTIANDROGENIC

ROUTE (list)

ORAL

ATC code

L02BB01

PK parameters

F 100 PERCENT
Tmax 1.3 HOUR
PPB 95 PERCENT
t1/2 7.8 HOUR

Target

TARGET ANDROGEN RECEPTOR

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

Formula:
C11H11F3N2O3

Calculated chemical properties:

MW 276.22
NB_atoms 19
XLogP 0
PSA 62.758
NB_HD 1
NB_HA 4
fsp3 0.36
Lipinski(0=no;1=yes) 1

FDA
NDA 018554 (pdf not found) INN (FLUTAMIDE) EULEXIN (SCHERING) APPROVAL= AP YEAR= 1989 DISCONTINUED
NDA 075298 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (WAYLIS THERAP) APPROVAL= AP YEAR= 2001
NDA 075780 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (CIPLA) APPROVAL= AP YEAR= 2001 DISCONTINUED
NDA 075818 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2001 DISCONTINUED
NDA 075820 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (ACTAVIS LABS FL INC) APPROVAL= AP YEAR= 2001 DISCONTINUED
NDA 076224 (pdf not found) INN (FLUTAMIDE) FLUTAMIDE (PHARMOBEDIENT) APPROVAL= AP YEAR= 2003 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL